Efficacy and Safety Study of Magnesium Isoglycyrrhizinate Injection in Subjects With Acute Drug-induced Liver Injury

NCT02734966 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

174

Enrollment

INDUSTRY

Sponsor class

Conditions

Drug-Induced Liver Injury

Interventions

DRUG: Magnesium Isoglycyrrhizinate Injection 100mg OD
DRUG: Magnesium Isoglycyrrhizinate Injection 200mg OD
DRUG: Tiopronin Injection

Sponsor

Chia Tai Tianqing Pharmaceutical Group Co., Ltd.